BioLOGIC Episode:1
Elena Gianulis, PhD. sets the stage in the inaugural segment by delivering a high-level introduction to the captivating realm of allografts.
BioLOGIC Episode:2
In the second installment of the Biologic Chat series, we delve deeper into the heart of our mission at LifeNet Health. Brad Wetzell, PhD, sheds light on why we approach allograft donors and allografts with profound respect and reverence, distinguishing these remarkable gifts from conventional "cadaver" tissue.
BioLOGIC Episode:3
An allograft? An autograft? What's the difference, and why does it matter? Dr. Wetzel provides insights into the thought process behind this decision, shedding light on the factors that shape a surgeon's choice.
Dr. Wetzel also highlights the pivotal role that LifeNet Health plays in this arena. Our unwavering commitment to quality and excellence sets us apart. We are proud to stand at the forefront of tissue transplantation, providing the best options for patients and surgeons alike.
BioLOGIC Episode:4
The latest edition of BioLOGIC Chats highlights LifeNet Health’s propriety sterilization technology, Allowash XG®. It virtually eliminates bacterial and viral risks to ensure the safest possible allografts. Is allograft sterility a priority for your tissue bank?
BioLOGIC Episode:5
Julie McLean PhD discusses healthcare economics. In a retrospective study including over 16,000 US surgeries, viable bone allografts showed $50K less in initial charges and $22,091 less in 12-month follow-up costs compared to rhBMP-2. Both solutions exhibited similar subsequent fusion rates and hospital readmissions.
BioLOGIC Episode:6
Explore the differences between sterilized and aseptically-processed tendon allografts with Dr. Brad Wetzell. We'll discuss why not all tissue banks sterilize their tendons and highlight LifeNet Health's innovative Allowash XG technology, which ensures sterility without compromising clinical effectiveness.
